UBS Group’s Connect Biopharma Holdings Limited Ordinary Shares CNTB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41 | Sell |
42
-8,697
| -100% | -$8.49K | ﹤0.01% | 8740 |
|
|
2025
Q1 | $4.81K | Buy |
8,739
+4,006
| +85% | +$2.2K | ﹤0.01% | 7747 |
|
|
2024
Q4 | $6.53K | Buy |
+4,733
| New | +$6.53K | ﹤0.01% | 7316 |
|
|
2023
Q2 | – | Sell |
-9,336
| Closed | -$9.34K | – | 7885 |
|
|
2023
Q1 | $9.34K | Sell |
9,336
-8,798
| -49% | -$8.8K | ﹤0.01% | 6568 |
|
|
2022
Q4 | $15.8K | Buy |
18,134
+17,638
| +3,556% | +$15.3K | ﹤0.01% | 6766 |
|
|
2022
Q3 | $1K | Sell |
496
-104,689
| -100% | -$211K | ﹤0.01% | 8828 |
|
|
2022
Q2 | $91K | Buy |
105,185
+103,324
| +5,552% | +$89.4K | ﹤0.01% | 4504 |
|
|
2022
Q1 | $6K | Buy |
1,861
+1,080
| +138% | +$3.48K | ﹤0.01% | 7900 |
|
|
2021
Q4 | $4K | Buy |
781
+346
| +80% | +$1.77K | ﹤0.01% | 8380 |
|
|
2021
Q3 | $11K | Buy |
+435
| New | +$11K | ﹤0.01% | 6724 |
|